| ASSET | QUARTER | % RETURN |
|---|---|---|
Nocera (NCRA) | Q2 2003 | 10,000% |
Pluri (PLUR) | Q2 2003 | 1,690% |
Encompass Health (EHC) | Q2 2003 | 477.79% |
Cogent Communications (CCOI) | Q2 2003 | 450% |
Smith Micro Software (SMSI) | Q2 2003 | 438.18% |
Encore Capital (ECPG) | Q2 2003 | 433.33% |
Curis (CRIS) | Q2 2003 | 357.5% |
Vera Therapeutics (VERA) | Q2 2003 | 328.57% |
Insmed (INSM) | Q2 2003 | 320.31% |
Natural Health Trend (NHTC) | Q2 2003 | 303.62% |
NetSol Technologies (NTWK) | Q2 2003 | 288.89% |
Live Ventures (LIVE) | Q2 2003 | 288.22% |
Filana Therapeutics (FLNA) | Q2 2003 | 279.41% |
Armata Pharmaceuticals (ARMP) | Q2 2003 | 279.17% |
CEL-SCI (CVM) | Q2 2003 | 250% |
Vericel Corp Ord (VCEL) | Q2 2003 | 248.28% |
Akamai Technologies (AKAM) | Q2 2003 | 231.94% |
Alpha Compute (ALP) | Q2 2003 | 220.7% |
Sohu (SOHU) | Q2 2003 | 215.99% |
Repro Med Systems (KRMD) | Q2 2003 | 213.33% |
Cheniere Energy (LNG) | Q2 2003 | 211.02% |
Omnicell (OMCL) | Q2 2003 | 204.89% |
QuickLogic (QUIK) | Q2 2003 | 203.77% |
Axon Enterprise (AXON) | Q2 2003 | 203.7% |
Intrusion (INTZ) | Q2 2003 | 200% |
